Increased expression of slug and vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer

Carcinogenesis

Volumn 34, Issue 11, 2013, Pages 2548-2557

  Toiyama, Yuji ^a,b   Yasuda, Hiromi ^a   Saigusa, Susumu ^a   Tanaka, Koji ^a   Inoue, Yasuhiro ^a   Goel, Ajay ^b   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR SLUG; TUMOR MARKER; VIMENTIN;

ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

AGED; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84886996188     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt282     Document Type: Article

References (38)

1. Jemal,A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277-300.
2. Andre,N. et al. (2005) Chemoradiotherapy for colorectal cancer. Gut, 54, 1194-1202.
3. Lurje,G. et al. (2007) Molecular prognostic markers in locally advanced colon cancer. Clin. Colorectal Cancer, 6, 683-690.
4. Halama,N. et al. (2008) Treatment with cetuximab, bevacizumab and irinotecan in heavily pretreated patients with metastasized colorectal cancer. Anticancer Res., 28(6B), 4111-4115.
5. Prall,F. (2007) Tumour budding in colorectal carcinoma. Histopathology, 50, 151-162.
6. Sohn,D.K. et al. (2007) Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J. Clin. Pathol., 60, 912-915.
7. Wang,H.S. et al. (2005) Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis. Colon Rectum, 48, 1182-1192.
8. Ueno,H. et al. (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br. J. Surg., 91, 327-333.
9. Gospodarowicz,M.K. et al. (2006) International Union Against Cancer (UICC). Prognostic Factors in Cancer. 3rd edn. Wiley, New York, NY.
10. Micalizzi,D.S. et al. (2009) Epithelial-mesenchymal transition in development and cancer. Future Oncol., 5, 1129-1143.
11. Satelli,A. et al. (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci., 68, 3033-3046.
12. Makrilia,N. et al. (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest., 27, 1023-1037.
13. Huber,M.A. et al. (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol., 17, 548-558.
14. Comijn,J. et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7, 1267-1278.
15. Yang,J. et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939.
16. Guaita,S. et al. (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem., 277, 39209-39216.
17. Savagner,P. et al. (1998) Slug mRNA is expressed by specific mesodermal derivatives during rodent organogenesis. Dev. Dyn., 213, 182-187.
18. Carl,T.F. et al. (1999) Inhibition of neural crest migration in Xenopus using antisense slug RNA. Dev. Biol., 213, 101-115.
19. Catalano,A. et al. (2004) Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells. J. Biol. Chem., 279, 46706-46714.
20. Inoue,A. et al. (2002) Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell, 2, 279-288.
21. Kajita,M. et al. (2004) Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol. Cell. Biol., 24, 7559-7566.
22. Sivertsen,S. et al. (2006) Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer, 54, 309-317.
23. Kurrey,N.K. et al. (2005) Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol. Oncol., 97, 155-165.
24. Blanco,M.J. et al. (2002) Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene, 21, 3241-3246.
25. Blechschmidt,K. et al. (2007) The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagn. Mol. Pathol., 16, 222-228.
26. Jin,H. et al. (2010) Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int. J. Cancer, 126, 2102-2111.
27. Mikami,S. et al. (2011) Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab. Invest., 91, 1443-1458.
28. Uchikado,Y. et al. (2011) Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer, 14, 41-49.
29. Uchikado,Y. et al. (2005) Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin. Cancer Res., 11, 1174-1180.
30. Shioiri,M. et al. (2006) Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer, 94, 1816-1822.
31. Baddi,L. et al. (2005) Adjuvant therapy in stage II colon cancer: current approaches. Oncologist, 10, 325-331.
32. von Bassewitz,D.B. et al. (1982) Intermediate-sized filaments in cells of normal human colon mucosa, adenomas and carcinomas. Pathol. Res. Pract., 175, 238-255.
33. Ngan,C.Y. et al. (2007) Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br. J. Cancer, 96, 986-992.
34. Vogetseder,W. et al. (1989) Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int. J. Cancer, 43, 768-773.
35. Nakamura,T. et al. (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res., 57, 3305-3313.
36. Orimo,A. et al. (2001) Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin. Cancer Res., 7, 3097-3105.
37. Olumi,A.F. et al. (1998) A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death. Cancer Res., 58, 4525-4530.
38. Pages,F. et al. (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med., 353, 2654-2666.